The next set of investor relations (IR) questions and responses from biotechs provided by Mike O'Neill has been posted, covering financials and upcoming catalysts for each biotech stock.
This round of responses (received between September 2012 and January 2013) features Albany Medical Research $AMRI, EntreMed $ENMD, Advanced Cell Technology $ACTC, Transition Therapeutics $TTHI, and Theragenics $TGX.
Check out the complete index of all IR Questions and Answers if you missed the previous editions (now with 40 entries and counting!)
This round of responses (received between September 2012 and January 2013) features Albany Medical Research $AMRI, EntreMed $ENMD, Advanced Cell Technology $ACTC, Transition Therapeutics $TTHI, and Theragenics $TGX.
Check out the complete index of all IR Questions and Answers if you missed the previous editions (now with 40 entries and counting!)
RSS Feed
